Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Zack's

<< Previous

Bullboard Posts

Next >>

Post by kuatoliveson Aug 11, 2016 6:53pm

126 Views

Post# 25133337

Zack's

Zacks as a new research report on ARLZ. Can't seem to link to it other than from my phone, but long story short they're putting $10 on the shares (plus or minus) with another tidbit that most of the offers to their 110 drug reps are contingent on yosprala approval.

We seem to be gaining some momentum ahead of the PDUFA date. Nice to see some green numbers for a change. At most 4 more weeks before the FDA coughs up an answer.....

<< Previous

Bullboard Posts

Next >>

Increasing summer travel could see these airline stocks soar